Citadel Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $259K | Sell |
|
|||||
|
2024
Q4 | $246K | Buy |
|
|||||
|
2024
Q3 | $50 | Buy |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $36.4K | Buy |
|
|||||
|
2023
Q3 | $16.2K | Sell |
|
|||||
|
2023
Q2 | $40.9K | Buy |
|
|||||
|
2023
Q1 | $4.9K | Sell |
|
|||||
|
2022
Q4 | $58.2K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $49K | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $24K | Sell |
|
|||||
|
2021
Q2 | $227K | Buy |
|
|||||
|
2021
Q1 | $40K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $56K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $10K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $11K | Sell |
|
|||||
|
2017
Q1 | $52K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $76K | Buy |
|
|||||
|
2016
Q2 | $49K | Buy |
|
|||||
|
2016
Q1 | $107K | Sell |
|
|||||
|
2015
Q4 | $219K | Sell |
|
|||||
|
2015
Q3 | $471K | Buy |
|
|||||
|
2015
Q2 | $228K | Sell |
|
|||||
|
2015
Q1 | $776K | Buy |
|
|||||
|
2014
Q4 | $57K | Buy |
|